FI945085A - Yhdistelmä-neu-reseptoristimulaatiotekijä - Google Patents

Yhdistelmä-neu-reseptoristimulaatiotekijä Download PDF

Info

Publication number
FI945085A
FI945085A FI945085A FI945085A FI945085A FI 945085 A FI945085 A FI 945085A FI 945085 A FI945085 A FI 945085A FI 945085 A FI945085 A FI 945085A FI 945085 A FI945085 A FI 945085A
Authority
FI
Finland
Prior art keywords
receptorstimulantfaktor
neu
recombinant
recombinant neu
neu receptorstimulantfaktor
Prior art date
Application number
FI945085A
Other languages
English (en)
Swedish (sv)
Other versions
FI945085A0 (fi
Inventor
Duanzhi Wen
Yosef Yarden
Elior Peles
Original Assignee
Amgen Inc
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc, Yeda Res & Dev filed Critical Amgen Inc
Publication of FI945085A publication Critical patent/FI945085A/fi
Publication of FI945085A0 publication Critical patent/FI945085A0/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475Growth factors; Growth regulators
    • C07K14/4756Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI945085A 1992-04-29 1994-10-28 Yhdistelmä-neu-reseptoristimulaatiotekijä FI945085A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87743192A 1992-04-29 1992-04-29
PCT/US1993/004128 WO1993022424A1 (en) 1992-04-29 1993-04-28 RECOMBINANT STIMULATING FACTOR OF THE neu RECEPTOR

Publications (2)

Publication Number Publication Date
FI945085A true FI945085A (fi) 1994-10-28
FI945085A0 FI945085A0 (fi) 1994-10-28

Family

ID=25369947

Family Applications (1)

Application Number Title Priority Date Filing Date
FI945085A FI945085A0 (fi) 1992-04-29 1994-10-28 Yhdistelmä-neu-reseptoristimulaatiotekijä

Country Status (11)

Country Link
EP (1) EP0583050A3 (fi)
JP (1) JPH07506488A (fi)
KR (1) KR950701379A (fi)
CN (1) CN1080959A (fi)
AU (1) AU4228693A (fi)
CA (1) CA2134564A1 (fi)
FI (1) FI945085A0 (fi)
MX (1) MX9302475A (fi)
NO (1) NO944112L (fi)
WO (1) WO1993022424A1 (fi)
ZA (1) ZA933021B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530109A (en) * 1991-04-10 1996-06-25 Ludwig Institute For Cancer Research DNA encoding glial mitogenic factors
US7135456B1 (en) 1991-04-10 2006-11-14 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
US7094749B1 (en) 1991-04-10 2006-08-22 Acorda Therapeutics, Inc. Glial mitogenic factors, their preparation and use
US7285531B1 (en) 1991-04-10 2007-10-23 Acorda Therapeutics, Inc. Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor
US7319019B1 (en) 1991-04-10 2008-01-15 Acorda Therapeutics, Inc. Glial mitogenic factors lacking an N-terminal signal sequence
US5834229A (en) 1991-05-24 1998-11-10 Genentech, Inc. Nucleic acids vectors and host cells encoding and expressing heregulin 2-α
US5367060A (en) * 1991-05-24 1994-11-22 Genentech, Inc. Structure, production and use of heregulin
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin
WO1994028133A1 (en) * 1993-05-21 1994-12-08 Amgen Inc. Recombinant neu differentiation factors
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US5633161A (en) 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
AU727606B2 (en) * 1996-07-12 2000-12-14 Genentech Inc. Gamma-heregulin
WO1998035036A1 (en) * 1997-02-10 1998-08-13 Genentech, Inc. Heregulin variants
US6136558A (en) * 1997-02-10 2000-10-24 Genentech, Inc. Heregulin variants
US20010023241A1 (en) 1998-02-04 2001-09-20 Sliwkowski Mark X. Use of heregulin as a growth factor
CA2455830C (en) 2001-07-31 2012-10-09 Wayne State University Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans
DK2420565T3 (en) 2006-02-23 2017-12-04 Viacyte Inc APPLICABLE COMPOSITIONS AND METHODS FOR CULTIVATING DIFFERENTIBLE CELLS
CA2907326A1 (en) 2008-11-04 2010-05-14 Chad Green Stem cell aggregate suspension compositions and methods for differentiation thereof
AU2013248265B2 (en) 2012-11-08 2018-11-01 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO921040L (no) * 1991-03-17 1992-09-18 Yeda Res & Dev Stimulerende faktor for neu-reseptoren
IL101943A0 (en) * 1991-05-24 1992-12-30 Genentech Inc Structure,production and use of heregulin

Also Published As

Publication number Publication date
CN1080959A (zh) 1994-01-19
CA2134564A1 (en) 1993-11-11
ZA933021B (en) 1993-11-12
NO944112L (no) 1994-12-29
FI945085A0 (fi) 1994-10-28
WO1993022424A1 (en) 1993-11-11
AU4228693A (en) 1993-11-29
EP0583050A3 (en) 1994-10-05
NO944112D0 (no) 1994-10-28
KR950701379A (ko) 1995-03-23
MX9302475A (es) 1994-05-31
EP0583050A2 (en) 1994-02-16
JPH07506488A (ja) 1995-07-20

Similar Documents

Publication Publication Date Title
DE69315842D1 (de) Peptidverbindungen
DK91192D0 (da) Protein
FI945085A (fi) Yhdistelmä-neu-reseptoristimulaatiotekijä
FI945928A (fi) Rekombinanttiksylanaasit
DK132892D0 (da) Proteiner
AT399443B (de) Sportschuh
FI931089A0 (fi) Substituerade fenylaettikssyraamider
FI931711A (fi) Stoedfot foer kran i kompositmaterial
FI933038A0 (fi) Matningssystem foer presspartiet i en pappermaskin
ATA236892A (de) Rotornut
FI923709A (fi) I en saekerhetsskena laosbar vagn
FI931058A (fi) Rakelbalk foer faergningsanordningen i en tryckmaskin
LV10286A (lv) Peptidu savienojumi
DK144292D0 (da) Forbedret fremgangsmaade
FI933485A0 (fi) Avrinningsinsats foer montering i existerande avrinningsbassaeng
LV10287A (lv) Peptidu savienojumi
FI925685A0 (fi) Foerfarande i foerbraenningsmotorprocess
FI922527A (fi) Vaeggkonstruktion foer anordning i byggnader
DK120792D0 (da) Protein
DE59303468D1 (de) Stabilisierte Aminobenzotrifluoride
SE9203175D0 (sv) Growth hormone
FI377U1 (fi) Bakgrundselement foer vaermebatterier i byggnader
FI717U1 (fi) Lucka foer montering i takplaot
FI802U1 (fi) Appliceringsbalk i en limpress
FI420U1 (fi) I en saekerhetsskena laosbar vagn

Legal Events

Date Code Title Description
FD Application lapsed